| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |